Form 4 for NPCE NeuroPace Inc
Accepted 2026-03-04 00:00:00 ET · period of report 2025-12-15 · accession 0001855616-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 2025-12-15 | NPCE | Morrell Martha | Chief MEDICAL Off | S - Sale | $15.97 | -25.0K | 50.0K | -33% | -$399.2K | |
| 2026-03-04 | 2026-03-03 | NPCE | Morrell Martha | Chief MEDICAL Off | F - Tax | $13.83 | -1,340 | 48.6K | -3% | -$18.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-15 | S | D | 25,000 | $15.97 | 49,964 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.83 to $16.26, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form. |
| 2 | Common | Common Stock | 2026-03-03 | F | D | 1,340 | $13.83 | 48,624 | D | — | — | (F3) Represents the number of shares withheld by the Issuer on March 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. |